2020 Virtual UK Oncology Forum now fully available online March 2021 The recorded 2020 Virtual UK Oncology Forum is now fully available to view on the UK Oncology Forum virtual platform. This national, clinically focussed meeting was […]
Pharmacogenomic testing for DPYD polymorphisms prior to fluoropyrimidine chemotherapy February 2021 | By Martin Bradley In November 2020, NHS England issued an urgent policy statement confirming the routine commissioning of pharmacogenomic testing prior to the initiation of fluoropyrimidine chemotherapy.1 This […]
Systemic anticancer treatments during COVID-19 and beyond February 2021 | By Alastair Whitington The UK Chemotherapy Board Annual Conference 2020 was held on 26 November 2020 as a virtual event. In this quarter’s Oncology Corner column, Alastair Whitington, […]
Draft guidance approves niraparib for ovarian cancer February 2021 NICE has published its final appraisal document on niraparib for maintenance treatment of advanced ovarian, fallopian tube, and peritoneal cancer. According to the draft guidance, […]
Proton beam therapy: a new radiotherapy paradigm December 2020 | By Roger Taylor and Melanie Kay Radiotherapy is an important curative component of treatment for nearly half of all patients with cancer.1 Proton beam therapy (PBT) is a specialised form of […]
Restarting cancer services will require stratification and coordination December 2020 | By Nina Buchan As part of the Virtual UK Oncology Forum 2020, The Big COVID/Cancer Debate took place online on 25 September 2020. This fringe meeting, which was […]
